← Back to All Filings

CoreWeave Officer Sells Over $245M in Stock via 10b5-1 Plan

High SignificanceDecember 15, 2025 at 9:34:05 PM UTC

CoreWeave, Inc.

144CIK: 0001769628

Filing Summary

CoreWeave Officer Sells Over $245M in Stock via 10b5-1 Plan

Company: CoreWeave, Inc. (N/A) Form: 144 | Filed: 2025-12-15 Significance: High

Insider: McBee Brannin (and associated trusts) Title: Officer | Relationship: Officer

Transaction (Aggregate Past 3 Months): • Type: Sale (via 10b5-1 plan) • Shares: 2,148,976 • Price: Various (Avg ~$114.25) • Value: $245,517,958 • Owned After: Not Disclosed

Key Insight: A Form 144 notice for a small proposed sale has revealed a series of substantial sales by an officer totaling over $245 million in the last three months. These sales represent 0.56% of the company's total shares outstanding.

Market Context: The sales were executed under a pre-arranged 10b5-1 trading plan, which can be for personal financial planning. However, the sheer volume of the disposition is a significant data point for investors monitoring insider sentiment at the $38.55B company.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: CoreWeave, Inc. (N/A)

Executive Summary

  • Trading Significance: High
  • Key Takeaway: A CoreWeave officer, McBee Brannin, and associated trusts have sold over $245 million worth of company stock in the past three months under a 10b5-1 plan.
  • Market Impact: While executed under a pre-arranged plan, the sale of over 2.1 million shares introduces a significant supply to the market and provides a notable signal of insider profit-taking.

Company Information

FieldValue
CompanyCoreWeave, Inc.
Ticker SymbolNot specified in filing
CIK0001769628
IndustrySERVICES-PREPACKAGED SOFTWARE

Insider Information

FieldValue
NameMcBee Brannin (and associated trusts)
CIK0002058103
Title/PositionOfficer
RelationshipOfficer

Transaction Details

This Form 144 filing for a proposed sale of 500 shares disclosed a series of significant sales over the prior three months. The analysis focuses on the aggregate of these past transactions.

FieldValue
Form Type144
Transaction DateSept 2025 - Dec 2025
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved2,148,976 (aggregate)
Price Per ShareVarious
Total Value$245,517,958.16 (aggregate)
Shares Owned AfterNot Disclosed
Ownership TypeIndirect / Direct

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$245.52 million
% of Market Cap0.64%
Shares Transacted2,148,976
% of Shares Outstanding0.56%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentHighly Significant

Impact Evaluation

  • Market Cap Context: For a company with a $38.55 billion market capitalization, a $245 million sale represents a notable but not overwhelming 0.64% of its value. The significance is elevated by the share percentage.
  • Ownership Concentration: The filing does not disclose the insider's total holdings, making it impossible to determine the percentage of their personal stake that was sold.
  • Dilution Impact: Not applicable, as this is a secondary sale of existing shares, not an issuance of new equity.
  • Transaction Significance: The transaction is deemed Highly Significant because the number of shares sold (2.15M) exceeds the 0.5% threshold of total shares outstanding (386.4M). This indicates a material change in the market supply from a key insider.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sales were conducted under a 10b5-1 plan adopted on September 2, 2025. This pre-arranged plan mitigates concerns that the sales were based on immediate, non-public information. However, the consistent, high-volume selling could place downward pressure on the stock price due to increased supply.

Volume & Sentiment

  • Expected Volume Impact: The transactions have already contributed to trading volume over the past three months. The ongoing nature of the 10b5-1 plan suggests continued insider sale volume is possible.
  • Sentiment Indicator: Neutral to Bearish. While 10b5-1 plans are common for executive diversification and liquidity, the sheer scale of the selling ($245M) is a bearish data point that outweighs the procedural neutrality of the plan.

Investment Insights

Positive Market Indicators

  • The transactions were part of a pre-scheduled plan, not a panic sell.

Risk Factors

  • A key officer is liquidating a substantial position, which can be perceived as a lack of confidence in the company's near-term growth prospects.
  • The continuous sale of over 2 million shares increases the available float and could create a price ceiling or downward pressure.

Key Takeaways

  1. A CoreWeave officer is engaged in a significant, systematic liquidation of stock, totaling over $245 million.
  2. The volume of shares sold represents over 0.5% of the company's total shares outstanding, meeting the threshold for a highly significant event.
  3. The use of a 10b5-1 plan suggests the sales are for planned liquidity rather than a reaction to new negative information, but the magnitude of the selling remains a key bearish indicator for investors to monitor.

Additional Context

Transaction Notes

  • Special Circumstances: The sales were executed by the officer and multiple trusts associated with him, all under a 10b5-1 trading plan. This indicates a coordinated and planned diversification strategy.
Topics:#CoreWeave#SECFiling#Form144#InsiderTrading#InsiderSell#HighSignificance#StockAlert#TechStocks#Investing#10b51

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.